Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.7499/j.issn.1008-8830.2007212 http://scihub22266oqcxt.onion/10.7499/j.issn.1008-8830.2007212 33476539!7818160!33476539     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33476539&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Warning: Undefined variable $yww in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 538 Warning: Undefined variable $yww in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 538       Zhongguo+Dang+Dai+Er+Ke+Za+Zhi 2021 ; 23 (1): 61-66 Nephropedia Template TP {{tp|p=33476539|t=2021. A retrospective analysis of medication in children with SARS-CoV-2 infection in Wuhan, China |pdf=|usr=}}{{33476539}} gab.com Text A retrospective analysis of medication in children with SARS-CoV-2 infection in Wuhan, China JO: Zhongguo Dang Dai Er Ke Za Zhi http://www.kidney.de/pget.php?&tw=1&pmid=33476539 #FOAvip OBJECTIVE: To study the medication in children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Wuhan, China, and to provide a reference for rational drug use in clinical practice. METHODS: A retrospective analysis was performed on the medical data of the children who were diagnosed with SARS-CoV-2 infection from January 26 to March 5, 2020. The children were divided into an asymptomatic group with 41 children and a symptomatic group with 73 children. A subgroup analysis was performed to investigate the effect of different antiviral regimens (monotherapy, double therapy, or triple therapy) and whether interferon alpha-1b was used in combination with azithromycin on the length of hospital stay and the clearance time of SARS-CoV-2 nucleic acid. RESULTS: A total of 114 children with SARS-CoV-2 infection (72 boys and 42 girls) were enrolled. The median age of the children was 7.1 years. The median length of hospital stay was 10 days and the clearance time of SARS-CoV-2 nucleic acid was 6 days. In either group, the subgroup analysis showed no significance differences in the length of hospital stay and the clearance time of SARS-CoV-2 nucleic acid between the subgroups treated with different combinations of antiviral drugs and the subgroups treated with interferon alpha-1b alone or in combination with azithromycin (P > 0.05). CONCLUSIONS: It is not recommended to use the routine combinations of antiviral drugs for children with SARS-COV-2 infection or combine with azithromycin for the purpose of antiviral therapy. Twit Text FOAVip A retrospective analysis of medication in children with SARS-CoV-2 infection in Wuhan, China ????Zhongguo Dang Dai Er Ke Za Zhi http://www.kidney.de/pget.php?&tw=1&pmid=33476539 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33476539 #FOAvip English Wikipedia <ref>{{Cite pmid|33476539}}</ref> A retrospective analysis of medication in children with SARS-CoV-2 infection in Wuhan, China #MMPMID33476539 DU ZS; Xu H; Liu MC Zhongguo Dang Dai Er Ke Za Zhi 2021[Jan]; 23 (1): 61-66 PMID33476539show ga OBJECTIVE: To study the medication in children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Wuhan, China, and to provide a reference for rational drug use in clinical practice. METHODS: A retrospective analysis was performed on the medical data of the children who were diagnosed with SARS-CoV-2 infection from January 26 to March 5, 2020. The children were divided into an asymptomatic group with 41 children and a symptomatic group with 73 children. A subgroup analysis was performed to investigate the effect of different antiviral regimens (monotherapy, double therapy, or triple therapy) and whether interferon alpha-1b was used in combination with azithromycin on the length of hospital stay and the clearance time of SARS-CoV-2 nucleic acid. RESULTS: A total of 114 children with SARS-CoV-2 infection (72 boys and 42 girls) were enrolled. The median age of the children was 7.1 years. The median length of hospital stay was 10 days and the clearance time of SARS-CoV-2 nucleic acid was 6 days. In either group, the subgroup analysis showed no significance differences in the length of hospital stay and the clearance time of SARS-CoV-2 nucleic acid between the subgroups treated with different combinations of antiviral drugs and the subgroups treated with interferon alpha-1b alone or in combination with azithromycin (P > 0.05). CONCLUSIONS: It is not recommended to use the routine combinations of antiviral drugs for children with SARS-COV-2 infection or combine with azithromycin for the purpose of antiviral therapy. |*COVID-19[MESH] |Antiviral Agents/therapeutic use[MESH] |Child[MESH] |China[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Retrospective Studies[MESH] A retrospective analysis of medication in children with SARS-CoV-2 in(epmc).pdf DeepDyve Pubget Overpricing